Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
32.01 Down 0.25(0.77%) May 22, 4:00PM EDT
|After Hours : 31.00 Down 1.01 (3.16%) May 22, 5:51PM EDT
Add to Portfolio
Prev Close:32.26
Open:32.08
Bid:27.80 x 100
Ask:31.90 x 100
1y Target Est:42.55
Beta:1.3
Earnings Date:Jul 29 - Aug 3 (Est.)
Day's Range:31.92 - 32.19
52wk Range:28.26 - 45.45
Volume:476,003
Avg Vol (3m):655,322
Market Cap:1.37B
P/E (ttm):96.71
EPS (ttm):0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORDown 0.77%1.37B
BIIBDown 0.62%93.78B
TEVADown 0.60%51.77B

Key Statistics

Forward P/E (1 yr):34.42
P/S (ttm):3.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.58
Quarterly EPS Est (Jun-15) :0.17
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.50

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback